|Other Names||CD177 antigen, Human neutrophil alloantigen 2a, HNA-2a, NB1 glycoprotein, NB1 GP, Polycythemia rubra vera protein 1, PRV-1, CD177, CD177, NB1, PRV1|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Cell membrane; Lipid-anchor, GPI-anchor|
|Tissue Location||Highly expressed in normal bone marrow and weakly expressed in fetal liver. Expressed on neutrophils Expressed in granulocytes of patients with polycythemia vera (PV) and with essential thrombocythemia (ET)|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
NB1, a glycosyl-phosphatidylinositol (GPI)-linked N-glycosylated cell surface glycoprotein, was first described in a case of neonatal alloimmune neutropenia.
Melis, S., et al. Acta Clin Belg 64(5):429-433(2009)Hu, N., et al. Autoimmun Rev 8(6):510-514(2009)Korkmaz, B., et al. J. Biol. Chem. 283(51):35976-35982(2008)Han, T.H., et al. Korean J Lab Med 26(2):114-118(2006)Kissel, K., et al. Eur. J. Immunol. 31(5):1301-1309(2001)Temerinac, S., et al. Blood 95(8):2569-2576(2000)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.